Puerto Rico’s iPR Pharmaceuticals launches US$9.7 million Bio solar park in Canóvanas

Puerto Rico’s iPR Pharmaceuticals inaugurated its Bio Solar Park in Canóvanas featuring 3,709 solar panels and a 2 MW battery system, with a US$9.7 million investment. The project generates energy equivalent to about 330 homes and supports the pharmaceutical plant’s operations, which produce medications for export to over 120 countries. The Bio Solar Park builds on iPR’s previous energy initiatives, including an LNG cogeneration plant and an earlier photovoltaic installation.

Source: PV Magazine LATAM